Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,779 total articles

ZenaTech's ZenaDrone Subsidiary and Defense Solutions in the Spotlight at Company’s Largest Ever Presence at AUVSI Exponential 2026 Conference and Tradeshow in Detroit

ZenaTech's ZenaDrone Subsidiary and Defense Solutions in the Spotlight at Company’s Largest Ever Presence at AUVSI Exponential 2026 Conference and Tradeshow in Detroit

ZenaTech, Inc. (Nasdaq: ZENA) announced that its subsidiary ZenaDrone will showcase its most comprehensive defense-focused drone hardware, software, and Drone as a Service (DaaS) at the AUVSI Xponential 2026 conference in Detroit. The company will engage defense, government, and enterprise stakeholders with live demonstrations, a podcast studio, an…

Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET

Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET

Harvard Bioscience, a life sciences technology developer, declared that it will release quarterly financial results for Q1 2026 on May 12 before market open and host a conference call to discuss these results. The company provides technologies and services supporting research and pharmaceutical development globally, with operations in the US, Europ…

NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans

NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans

NorthStrive Biosciences Inc., a subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), announced the filing of a new US patent application covering the development of EL-22, a myostatin-engineered probiotic technology, for pharmaceutical use targeting muscle loss conditions in humans. The patent includes protection for specific dosing regimens and formul…

Streamex Corp. Announces First Yield Dividend Distribution for GLDY

Streamex Corp. Announces First Yield Dividend Distribution for GLDY

Streamex Corp. (NASDAQ: STEX) announced the first yield distribution for GLDY, a gold-backed, yield-bearing tokenized security. The yield, generated through a gold leasing program with an annualized lease yield of 3.5%, is distributed in additional GLDY tokens monthly. This milestone validates Streamex's infrastructure and product, bridging traditi…

Watsco First Quarter Performance Reflects Stabilizing Markets,  Improved Operating Efficiency and Expanded Technology Adoption

Watsco First Quarter Performance Reflects Stabilizing Markets, Improved Operating Efficiency and Expanded Technology Adoption

Watsco, Inc., the leading North American HVAC distributor, reported flat first quarter 2026 revenues and earnings, reflecting market stabilization following the A2L refrigerant transition. The company announced the pending acquisition of Jackson Supply Company, enhancing scale and diversification in its core Sunbelt markets. Watsco continues to inv…

Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health

Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health

Helus Pharma has partnered with mental health organization TARA Mind to support recruitment for its Phase 3 clinical trial of HLP003, a novel serotonergic agonist for major depressive disorder, specifically targeting veterans. This collaboration aligns with a recent U.S. Executive Order focusing on accelerating treatments for serious mental illness…

BridgeBio Launches Health Education Effort on Often Overlooked Heart Condition Featuring Attruby® Advocates, Morgan Freeman and Sports Business Icon Howard H. White

BridgeBio Launches Health Education Effort on Often Overlooked Heart Condition Featuring Attruby® Advocates, Morgan Freeman and Sports Business Icon Howard H. White

BridgeBio Pharma initiates a national educational campaign highlighting ATTR-CM, a frequently overlooked heart condition, to encourage earlier diagnosis and treatment. The campaign features advocates Morgan Freeman and Howard H. White and promotes their drug, Attruby®, which showed significant clinical benefits in reducing cardiovascular-related ho…

Cytokinetics Announces Nine Upcoming Presentations at the European Society of Cardiology Heart Failure 2026 Congress

Cytokinetics Announces Nine Upcoming Presentations at the European Society of Cardiology Heart Failure 2026 Congress

Cytokinetics announced nine presentations at the European Society of Cardiology Heart Failure 2026 Congress, focusing largely on its cardiac myosin inhibitor MYQORZO® (aficamten), recently approved in major markets including the US, Europe, and China for symptomatic obstructive hypertrophic cardiomyopathy (oHCM). The presentations will highlight cl…

3D Systems Secures Class IIa EU MDR Certification for NextDent® Jetted Denture Solution, Enabling Full European Commercial Launch Two Months Ahead of Schedule

3D Systems Secures Class IIa EU MDR Certification for NextDent® Jetted Denture Solution, Enabling Full European Commercial Launch Two Months Ahead of Schedule

3D Systems announced that its NextDent Jet Base and Jet Teeth materials, along with the NextDent 300 MultiJet 3D printer, have achieved Class IIa certification under the EU Medical Device Regulation. This certification allows the immediate commercial launch of its flagship jetted denture solution across Europe two months ahead of schedule, signific…

Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Plus Therapeutics announced a new coverage agreement with Blue Shield of California for its CNSide® cerebrospinal fluid tumor cell assay, a diagnostic tool for metastatic CNS cancers. This agreement increases total covered lives from 75 million to 81 million, supporting the company's goal of 150 million by 2026 and enhancing adoption by reducing re…

Microchip Expands its Family of Post-Quantum‑Ready Root of Trust Controllers for Next‑Generation Systems

Microchip Expands its Family of Post-Quantum‑Ready Root of Trust Controllers for Next‑Generation Systems

Microchip Technology has expanded its portfolio of crypto-security controllers with the introduction of the TS1800 Platform Root of Trust controller and the TS50x secure boot controller, designed to support post-quantum cryptography (PQC) standards. These devices help address new cybersecurity regulations like the European Cyber Resilience Act and …

Sportradar Appoints Sameer Deen as Chief Operating Officer

Sportradar Appoints Sameer Deen as Chief Operating Officer

Sportradar Group AG announced the appointment of Sameer Deen as Chief Operating Officer effective May 18, 2026. Deen brings over 25 years of experience in sports betting, media, and digital commerce, previously serving as Chief Commercial Officer & President at Entain plc. His role will focus on overseeing commercial and group operations, leveragin…

uniQure to Announce First Quarter 2026 Financial Results

uniQure to Announce First Quarter 2026 Financial Results

uniQure N.V., a gene therapy company, announced it will release its first quarter 2026 financial results before market open on May 5, 2026, followed by an earnings call at 8:30 a.m. ET. The company highlighted its pioneering gene therapy for hemophilia B and ongoing advancement of therapies for several severe diseases including Huntington's disease…

reAlpha (Nasdaq: AIRE) Reports First-Quarter 2026 Financial Results

reAlpha (Nasdaq: AIRE) Reports First-Quarter 2026 Financial Results

reAlpha Tech Corp. announced Q1 2026 financial results showing a 9% revenue decline to $0.8 million, but a 119% increase in total transaction volume to $131.3 million. Gross margin improved to 66% driven by technology services. The company incurred a net loss of $4.3 million and adjusted EBITDA loss of $3.8 million, impacted by higher operating exp…

Sportradar Reports First Quarter 2026 Financial Results and Announces $250 Million Enhanced Open Market Share Repurchase Program

Sportradar Reports First Quarter 2026 Financial Results and Announces $250 Million Enhanced Open Market Share Repurchase Program

Sportradar Group AG reported an 11% increase in Q1 2026 revenue to €347 million and a 12% growth in adjusted EBITDA to €66 million. The company announced an enhanced $250 million share repurchase program and added Sameer Deen as COO. Sportradar reiterated its 2026 outlook with expected revenue growth of 23-25% on a constant currency basis and Adjus…

Studio City Announces Earnings Release Date

Studio City Announces Earnings Release Date

Studio City International Holdings Limited, a leading integrated resort in Cotai, Macau, announced that it will release its unaudited financial results for the first quarter of 2026 on April 30, 2026. The announcement includes a safe harbor statement detailing forward-looking risks such as changes in the Macau gaming market, economic conditions, re…